Partner Headlines - MDCO

  1. Mid-Afternoon Market Update: NASDAQ Down 1.3%; Medicines Company ...

    Benzinga
  2. Mid-Day Market Update: Crude Oil Surges 5.5%; ConforMIS Shares ...

    Benzinga
  3. Benzinga's Volume Movers

    Benzinga
  4. Mid-Morning Market Update: Markets Open Lower; Carlyle Group ...

    Benzinga
  5. Benzinga's Top #PreMarket Gainers

    Benzinga
  6. Benzinga's Top Upgrades

    Benzinga
  7. The Medicines Company Announces Participation at 2015 European ...

    Benzinga
  8. Volume And Volatility Alert: Medicines Company

    Benzinga
  9. Regeneron/Sanofi PCSK9 Cholesterol Drug Wins FDA OK

    IBD
  10. Medicines Co. gets upgrade

    IBD
  11. Medicines Co., Eagle Pharma Up On Analyst Actions

    IBD
  12. The Medicines Company Announces FDA Approval of KENGREAL as an ...

    Benzinga
  13. Netflix Profit Above Consensus, Panera Bread Boosts Buyback Plan, ...

    GuruFocus
  14. FDA Advisory Committee Recommends Approval of The Medicines Company's ...

    Benzinga
  15. Blood clot preventer gets nod

    IBD
  16. Earnings Scheduled For February 18, 2015

    Benzinga
  17. Tetraphase Fights Drug-Resistant Bugs As M&A Heats Up

    IBD
  18. Catalysts To Watch For In RBC Capital's 2015 Top Small-Cap Biotechs

    Benzinga
  19. Benzinga's Top Upgrades

    Benzinga
  20. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  21. What Investors Should Expect From Rockwell Medical's Next FDA ...

    Benzinga
  22. Mid-Morning Market Update: Markets Surge; Monsanto Profit Tops ...

    Benzinga
  23. Morning Market Losers

    Benzinga
  24. Tuesday's After-Hours Movers

    Benzinga
  25. The Medicines Company Surges Amid Credit Suisse Upgrade

    Benzinga
  26. US Stock Futures Surge Ahead Of Earnings, ADP Data

    Benzinga
  27. The Medicines Company Announces First Patient Enrollment In Phase ...

    Benzinga
  28. Midday Gainers From October 28: Buffalo Wild Wings, Integrated ...

    Benzinga
  29. Morning Market Movers

    Benzinga
  30. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga
  31. BACTIVTM Phase 3 SOLO II Trial Results Published In The Journal ...

    Benzinga
  32. Actavis Expands Antibiotics Presence With Durata Buy

    IBD
  33. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  34. Benzinga's Top Downgrades

    Benzinga
  35. Benzinga's Top Downgrades

    Benzinga
  36. Medicines Co.

    IBD
  37. Mid-Afternoon Market Update: Compuware Holds Onto Gains, Clearwire ...

    Benzinga
  38. Stocks Higher In Afternoon; Thor Industires Jumps

    IBD
  39. Mid-Day Market Update: Verint Shares Jump On Upbeat Results; ...

    Benzinga
  40. Medicines Co. Down On Setback In Hospira Patent Case

    IBD
  41. Stocks Hitting 52-Week Lows

    Benzinga
  42. Mid-Morning Market Update: Markets Gain; Ford March Sales Rise ...

    Benzinga
  43. Morning Market Losers

    Benzinga
  44. Benzinga's Top #PreMarket Losers

    Benzinga
  45. Medicines Co. earnings miss

    IBD
  46. Earnings Scheduled For February 19, 2014

    Benzinga
  47. FDA nixes Medicines' drug

    IBD
  48. Mid-Afternoon Market Update: Market Rally Levels Out As Time ...

    Benzinga
  49. Mid-Day Market Update: U.S. Stocks Rise; Orbitz Shares Surge ...

    Benzinga
  50. Medicines Co. Downgraded After FDA Panel Rejects Drug

    IBD
  51. Mid-Morning Market Update: Markets Drop; Comcast To Acquire Time ...

    Benzinga
  52. Stocks Hitting 52-Week Lows

    Benzinga
  53. UPDATE: Credit Suisse Downgrades The Medicines Company Following ...

    Benzinga
  54. Benzinga's Top #PreMarket Losers

    Benzinga
  55. UPDATE: The Medicines Co. Reminds Investors of FDA CRDAC Meeting ...

    Benzinga
  56. Mid-Afternoon Market Update: Red Robin Continues to Rally as ...

    Benzinga
  57. Leaders Hold Near Buy Points Despite Monday Sell-Off

    IBD
  58. Biotech Stocks Back On Top, Led By Biogen, Alexion

    IBD
  59. Scanning Leading Stocks For Earnings Growth In 2014

    IBD
  60. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  61. Medicines acquires Rempex

    IBD
  62. Benzinga's M&A Chatter for Wednesday December 4, 2013

    Benzinga
  63. Medicines Co. Acquires Rempex Pharma; Street Applauds

    IBD
  64. US Stock Futures Edge Higher Ahead Of ADP Report

    Benzinga
  65. Five Medical Stocks Leaders Trade Near New Highs

    IBD
  66. A Few Stocks Form Bases, But Have Flaws

    IBD
  67. Strong Pipeline Expected To Drive Growth At Medicines Co.

    IBD
  68. Medicines Co. Mostly Steady After Low-Volume Breakout

    IBD
  69. ViroPharma Gets Bought Out; Medicines Clears Entry

    IBD
  70. Santarus Earnings Should Top 4 Hot Small-Cap Medicals

    IBD
  71. Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  72. LinkedIn, Alliance Fiber Lead Q3 Young Gun Earnings

    IBD
  73. Medicines Co. In Late Stages Of Base Formation

    IBD
  74. Medicines Co. sales topped

    IBD
  75. Medicines Co. Reports Mixed Q3 As New Products Await

    IBD
  76. Medicines Co. Sales Beat Estimates As Angiomax Grows

    IBD
  77. UPDATE: Leerink Swann Raises PT on The Medicines Company Following ...

    Benzinga
  78. The Medicines Company, Alnylam Announce Advance Development ...

    Benzinga
  79. The Medicines Company's Publishes Phase III Data from Trials ...

    Benzinga
  80. UPDATE: Bank of America Upgrades Medicines Company on Leverage

    Benzinga
  81. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  82. The Medicines Company Announces Proposed Public Offering of 5.5 ...

    Benzinga
  83. The Medicines Company Announces Positive Phase III Trial Results ...

    Benzinga
  84. Questcor Leads Top 5 Small-Cap, Medical Stocks

    IBD
  85. The Medicines Co., Bristol-Myers Begin Alliance for Recothrom

    Benzinga
  86. Medicines Co. Holding On To Its Recent Big Gains

    IBD
  87. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 7,500 Shares

    GuruFocus
  88. Jefferies Reiterates Buy Rating, $34 PT on Partnership with Alnylam ...

    Benzinga
  89. A Peek Into The Market Before The Trading Starts

    Benzinga
  90. The Medicines Company, Alnylam Announce Global Alliance

    Benzinga
  91. Regeneron, Other Biomed Stocks Rebound On New Drugs

    IBD
  92. 3D Systems Leads Top 5 Small Caps Despite Stock Slide

    IBD
  93. Weekly CFO Sells Highlight: BK, MDCO, EBAY, MS, PHMD

    GuruFocus
  94. Weekly CFO Sells Highlight: MDCO, SIG, VCI, PHMD, SNPS

    GuruFocus
  95. Medicines (MDCO) President & CFO Glenn Sblendorio sells 125, ...

    GuruFocus
  96. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 2,500 Shares

    GuruFocus
  97. Small Cap Leaders: 3D Systems, IXIA Lead Top 5 Stocks

    IBD
  98. Celgene Leads 6 Medical Stocks With Bolting RS Lines

    IBD
  99. Medicines (MDCO) President & CFO Glenn Sblendorio sells 25,0 ...

    GuruFocus
  100. 5 Key Stock Moves From JPMorgan Health Care Confab

    IBD
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!